Janus Henderson Group’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,434
Closed -$48.4K 2428
2025
Q1
$48.4K Hold
16,434
﹤0.01% 2477
2024
Q4
$67.5K Hold
16,434
﹤0.01% 2516
2024
Q3
$73.5K Hold
16,434
﹤0.01% 2524
2024
Q2
$89.6K Sell
16,434
-264
-2% -$1.66K ﹤0.01% 2505
2024
Q1
$135K Buy
16,698
+10
+0.1% +$88 ﹤0.01% 2485
2023
Q4
$166K Buy
16,688
+17
+0.1% +$133 ﹤0.01% 2470
2023
Q3
$133K Buy
16,671
+1
+0% +$10 ﹤0.01% 2469
2023
Q2
$183K Buy
16,670
+10
+0.1% +$103 ﹤0.01% 2470
2023
Q1
$172K Buy
+16,660
New +$196K ﹤0.01% 2531
2022
Q3
Sell
-8,950
Closed -$205K 2280
2022
Q2
$205K Buy
+8,950
New +$191K ﹤0.01% 2290

Other funds holding DH

Janus Henderson Group's DH Position: Q2 2025 in Review

Janus Henderson Group sold out of Definitive Healthcare (DH) in Q2 2025, closing a stake of 16,434 shares — an estimated $48.4K sold.

Janus Henderson Group first reported a position in DH in Q2 2022 and held it in 10 quarters. The position peaked at $205K in Q2 2022. 121 funds tracked by Wall St. Rank hold DH as of Q2 2025.

  • Janus Henderson Group reported no remaining Definitive Healthcare position as of Q2 2025 after selling out during the quarter.
  • Janus Henderson Group sold 16,434 Definitive Healthcare shares in Q2 2025, an estimated $48.4K.
  • Janus Henderson Group first reported a position in Definitive Healthcare in Q2 2022 and held it in 10 quarters.
  • Janus Henderson Group's Definitive Healthcare position peaked at $205K in Q2 2022.
  • 121 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2025.

Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.